Impact of Pathologic Complete Response following Neoadjuvant Chemotherapy ± Trastuzumab in Locally Advanced Breast Cancer

Figure 3

(a) Disease-free survival (DFS) and (b) overall survival segregated by breast cancer molecular subtypes.

(a)

(b)